Harlow John B. Jr. bought ESPR
December 4, 2025 · Form 4 insider transaction
Harlow John B. Jr. bought 424,536 shares of Esperion Therapeutics, Inc. Common Stock at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
424,536
Price
$0.00
Total value
N/A
InsiderHarlow John B. Jr.
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateDecember 4, 2025
Filing dateDecember 8, 2025
Shares owned after424,536
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Such award will vest over a four (4) year period as follows: 25% shall vest on the respective one year anniversary of the vesting commencement date of December 15, 2025 and the remainder shall vest in equal quarterly installments over the three (3) year period thereafter.